Piramal Pharma shares gain 2% after EIR from USFDA for
WEB1 day ago · September 30, 2024 / 09:23 IST. Piramal Pharma. Piramal Pharma share price jumps 2 percent in the opening trade on September 30 after the company received Establishment Inspection Report (EIR) for ...
Piramal Pharma gains 8% as co aims for $2 billion revenue by …
WEB6 days ago · September 25, 2024 / 09:58 IST. Piramal Pharma Ltd. Shares of Piramal Pharma rose over 8 percent on September 25 after the company outlined its ambitious roadmap at a recent analyst meeting ...
Piramal Pharma Solutions Announces $80M Expansion Plan for …
WEB1 day ago · Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has unveiled an $80M ...
Piramal Pharma targets to double revenue in 5 years
WEB5 days ago · Mumbai: Piramal Pharma has set itself a target of reaching $2 billion in annual revenue with a 25% operating margin by fiscal 2030, largely led by its contract development and manufacturing organisation (CDMO) business. The Mumbai-based company is hoping to double its CDMO revenue by FY30. Piramal Pharma posted ₹8,171 crore ($987 million) of revenue in FY24, with CDMO contributing ₹4,750 ...
Piramal Pharma share price rises 8%: 3 key reasons why Jefferies …
WEB6 days ago · Piramal Pharma share price opened at ₹ 229.25 on Wednesday on the BSE, more than 5% higher than the previous closing price of ₹ 216.70. The Piramal Pharma share price thereafter went on to ...
Piramal Pharma soar 9% as co targets 2x revenue, 3x Ebitda …
WEB6 days ago · Piramal Pharma shares were in demand in the morning deals on Wednesday, as the shares gained 8.6 per cent intraday. The stock logged its day's high at Rs 235.35 per share on the BSE. The buying interest in the stock sparked after the pharma company revealed its ambitious revenue goal by the financial year 2030 (FY30).
Piramal Pharma Limited Announces Results for Q4 and FY2024
WEBMay 10, 2024 · Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full...
Piramal Pharma Limited Announces Consolidated Results for Q2 …
WEBOct 28, 2023 · Piramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results for the Second Quarter (Q2) and Half Year (H1)...
Piramal Pharma Limited Announces Consolidated Results for Q3 …
WEBMUMBAI, India, Jan. 30, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated...
Piramal Pharma aims to double turnover to $2 billion by 2030
WEB5 days ago · India Business News: Piramal Pharma plans to double its turnover to $2 billion by 2030, focusing on its CDMO business and high-growth sectors like complex hospital generic ... Piramal Pharma plans ...